Mutations in KIT are generally mutually exclusive with other driver mutations, including NRAS and BRAF. In our skin melanomas dataset, KIT mutations and CNVs are found in 4.5 and 2.3% of patients, respectively (Figures 2, 3 and Supplementary Figure S5C). This evidence concerns the gene BRAF and cutaneous melanoma.